Earnings Feed
Sign Up
Home/Filings/4/0001179110-10-000190
4//SEC Filing

BAGLEY RICHARD E 4

Accession 0001179110-10-000190

CIK 0001107421other
View on SEC.govCompany Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 2:44 PM ET

Size

20.5 KB

Accession

0001179110-10-000190

Insider Transaction Report

Form 4
Period: 2009-12-31
ZIOPHARM ONCOLOGY INCZIOP
BAGLEY RICHARD E
DirectorPresident, COO & Treasurer
Transactions
  • Award

    Common Stock, $.001 par value

    2009-12-31+50,000→ 209,125 total
  • Award

    Stock Option (right to buy)

    2009-12-31+50,000→ 50,000 total
    Exercise: $2.85Exp: 2019-12-31→ Common Stock (50,000 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $4.85Exp: 2017-06-18→ Common Stock (25,000 underlying)
    25,000

  • Stock Option (right to buy)

    Exercise: $5.01Exp: 2016-04-26→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (right to buy)

    Exercise: $6.49Exp: 2016-12-13→ Common Stock (20,000 underlying)
    20,000

  • Stock Option (right to buy)

    Exercise: $4.31Exp: 2015-09-13→ Common Stock (27,417 underlying)
    27,417

  • Stock Option (right to buy)

    Exercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (54,873 underlying)
    54,873

  • Stock Option (right to buy)

    Exercise: $2.73Exp: 2017-12-12→ Common Stock (75,000 underlying)
    75,000

  • Stock Option (right to buy)

    Exercise: $2.14Exp: 2018-06-25→ Common Stock (60,000 underlying)
    60,000

  • Stock Option (right to buy)

    Exercise: $0.70Exp: 2019-05-13→ Common Stock (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $1.70Exp: 2014-07-01→ Common Stock (150,668 underlying)
    150,668

  • Stock Option (right to buy)

    Exercise: $4.31Exp: 2015-06-08→ Common Stock (63,197 underlying)
    63,197
Footnotes (11)
  • [F1]50,223 shares vest on each of 7/1/05 and 7/1/06; 50,222 shares vest on 7/1/07.
  • [F10]Grant of restricted stock; restrictions lapse with respect to 16,667 shares on each of 12/31/2011 and 12/31/2012 and as to 16,666 shares on 12/31/2013.
  • [F11]16,667 shares vest on each of 12/31/2011 and 12/31/2012 and 16,666 shares vest on 12/31/2013.
  • [F2]21,066 shares vest on each of 7/1/05 and 7/1/06; 21,065 shares vest on 7/1/07.
  • [F3]9,139 shares vest on each of 9/13/05, 7/1/06 and 7/1/07.
  • [F4]20,000 shares vest immediately; the remainder vest on 12/14/06.
  • [F5]6,667 shares vest on each of 12/13/07 and 12/13/08; 6,666 shares vest on 12/13/09.
  • [F6]8,334 shares vest on 6/18/08; 8,333 shares vest on each of 6/18/09 and 6/18/10.
  • [F7]25,000 shares vest on each of 12/12/08, 12/12/09 and 12/12/10.
  • [F8]20,000 shares vest on each of 6/25/2009, 6/25/2010 and 6/25/2011.
  • [F9]25,000 shares vest immediately; 25,000 shares vest on each of 8/13/2009, 11/13/2009 and 2/13/2010.

Documents

1 file

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

→
Entity typeother

Related Parties

1
  • filerCIK 0001338559

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 2:44 PM ET
Size
20.5 KB
View on SEC.gov